Literature DB >> 10809182

Extracellular ATP inhibits starvation-induced apoptosis via P2X2 receptors in differentiated rat pheochromocytoma PC12 cells.

N Fujita1, M Kakimi, Y Ikeda, T Hiramoto, K Suzuki.   

Abstract

Apoptosis in neuronal tissue is an efficient mechanism which contributes to both normal cell development and pathological cell death. The present study explored the effects of extracellular ATP on starvation-induced apoptosis in rat pheochromocytoma PC12 cells. Incubation of differentiated PC12 cells with ATP for 6h suppressed apoptosis. 2-Methylthio-ATP, a P2 purinoceptor agonist, was as potent as ATP in suppressing apoptosis, whereas adenosine, ADP, alpha,betamethylene-ATP or UTP was totally ineffective. The suppressive action of ATP was dependent upon the presence of extracellular Ca2+ and blocked by co-incubation with the P2 antagonist, suramin. DNA ladder formation, a typical symptom of apoptosis in starved cells, was inhibited by ATP, 2-methylthio-ATP but not by UTP. These results suggest that the inhibitory action of extracellular ATP on apoptotic cell death is mediated via the activation of P2X2 receptors in differentiated PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809182     DOI: 10.1016/s0024-3205(00)00508-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

2.  Inhibitory effects of extracellular adenosine triphosphate on growth of esophageal carcinoma cells.

Authors:  Ming-Xia Wang; Lei-Ming Ren; Bao-En Shan
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 3.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

4.  The therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.

Authors:  Marc C E Wagner
Journal:  Curr HIV Res       Date:  2011-06       Impact factor: 1.581

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.